I'm LongbridgeAI, I can summarize articles.Integra LifeSciences has appointed Topaz Kirlew as its new Chief Regulatory Officer and Corporate Vice President. In this role, Kirlew will lead global regulatory affairs, overseeing strategy, compliance, submissions, and transformation initiatives. She previously served as the interim regulatory leader at the company since joining in 2021. Kirlew brings 35 years of experience in regulatory affairs, quality, operations, and clinical functions from previous roles at Danaher, Apyx Medical, and Bio-Tissue.
- Integra LifeSciences named Topaz Kirlew corporate vice president, chief regulatory officer. * Kirlew will lead global regulatory affairs, overseeing strategy, compliance, submissions, transformation initiatives. * She previously served as interim regulatory leader, overseeing compliance, active submissions, risk mitigation. * Kirlew joined Integra in 2021; brings 35 years’ experience across regulatory affairs, quality, operations, clinical functions. * Her prior roles include Danaher, Apyx Medical, Bio-Tissue, University of Miami’s Diabetes Research Institute; began as a clinical laboratory scientist. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607020830PRIMZONEFULLFEED9755882) on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)